Ligand Pharmaceuticals (LGND) Insider: Stock Move Analysis
A Ligand Pharmaceuticals insider recently sold 5,000 shares, triggering discussions about what insider moves signal f...
Repairing budgeting mistakes starts with mapping spend, prioritizing essentials, and resetting goals. Use a straightforward plan to correct course and build a durable budget.
17,946 articlesA Ligand Pharmaceuticals insider recently sold 5,000 shares, triggering discussions about what insider moves signal f...
Two very different apparel plays: FIGS targets a niche medical market with growth potential, while Gildan Activewear ...
Microsoft's latest quarterly dividend yields a nine-figure payment to Steve Ballmer, illustrating the power of long-t...
A Louisiana ice cream shop faced a scare and a payment trap after a threatening call claimed to be from Entergy. The ...
The cybersecurity talent gap is widening as AI skills grow faster than supply. A new market study shows hiring more s...
Trump declares the U.S.-Iran peace deal complete, sending stock futures higher and oil prices fluctuating. Yet analys...
A widely cited estimate of Genghis Khan's wealth—genghis khan worth $120—sparks a timely discussion on how historians...
PNC Bank has closed a $251.4 million affordable housing fund to expand the nation’s supply of affordable rentals, fin...
A Bloomberg-sparked rumor could change how AI compute is bought and sold. If Amazon starts selling its custom AI chip...
FOMO meets fundamentals. This guide breaks down how to evaluate a space tech megacap, manage risk, and decide if mont...
Two clean-energy stock contenders—EOS and Plug Power—promise very different routes to a low-carbon future. This deep ...
Viking Therapeutics trades around the low $30s as pivotal data for VK2735 approaches. This article breaks down whethe...